 Connection
Michael Rizzari to Living Donors
This is a "connection" page, showing publications Michael Rizzari has written about Living Donors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.174 |
|
|
|
-
Rizzari MD, Suszynski TM, Gillingham KJ, Matas AJ, Ibrahim HN. Outcome of living kidney donors left with multiple renal arteries. Clin Transplant. 2012 Jan-Feb; 26(1):E7-11.
Score: 0.295
-
Rizzari MD, Suszynski TM, Gillingham KJ, Matas AJ. Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors. Transplantation. 2011 Jul 15; 92(1):70-5.
Score: 0.289
-
Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson GE, Foley D, Mezrich JD, Kanmaz T, Andaçoglu OM, D'Alessandro AM, Acarli KS, Kalayoglu M, Fernandez LA. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter Turk J Med Sci. 2021 04 30; 51(2):610-622.
Score: 0.143
-
Takahashi K, Nagai S, Collins KM, Safwan M, Rizzari MD, Schnickel GT, Yoshida A, Abouljoud MS. Factors associated with low graft regeneration in the early phase after living donor liver transplantation. Clin Transplant. 2019 10; 33(10):e13690.
Score: 0.127
-
Safwan M, Nagai S, Collins K, Rizzari M, Yoshida A, Abouljoud M. Impact of abdominal shape on living liver donor outcomes in mini-incision right hepatic lobectomy: Comparison among 3 techniques. Liver Transpl. 2018 04; 24(4):516-527.
Score: 0.115
-
Rizzari MD, Suszynski TM, Gillingham KJ, Dunn TB, Ibrahim HN, Payne WD, Chinnakotla S, Finger EB, Sutherland DE, Kandaswamy R, Najarian JS, Pruett TL, Kukla A, Spong R, Matas AJ. Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol. 2012 Mar; 7(3):494-503.
Score: 0.075
-
Markmann JF, Abouljoud MS, Ghobrial RM, Bhati CS, Pelletier SJ, Lu AD, Ottmann S, Klair T, Eymard C, Roll GR, Magliocca J, Pruett TL, Reyes J, Black SM, Marsh CL, Schnickel G, Kinkhabwala M, Florman SS, Merani S, Demetris AJ, Kimura S, Rizzari M, Saharia A, Levy M, Agarwal A, Cigarroa FG, Eason JD, Syed S, Washburn WK, Parekh J, Moon J, Maskin A, Yeh H, Vagefi PA, MacConmara MP. Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial. JAMA Surg. 2022 03 01; 157(3):189-198.
Score: 0.038
-
Al-Kurd A, Kitajima T, Delvecchio K, Tayseer Shamaa M, Ivanics T, Yeddula S, Yoshida A, Rizzari M, Collins K, Abouljoud M, Nagai S. Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation. Transpl Int. 2021 Aug; 34(8):1422-1432.
Score: 0.036
-
Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Nagai S. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30. Liver Transpl. 2021 07; 27(7):971-983.
Score: 0.036
-
Suszynski TM, Gillingham KJ, Rizzari MD, Dunn TB, Payne WD, Chinnakotla S, Finger EB, Sutherland DER, Najarian JS, Pruett TL, Matas AJ, Kandaswamy R. Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. Am J Transplant. 2013 Apr; 13(4):961-970.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|